Highlander Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Highlander Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$64.1K	Hold	800	–	–	0.02%	353
2023 Q4	$60.9K	Hold	800	–	–	0.02%	359
2023 Q3	$58K	Hold	800	–	–	0.02%	354
2023 Q2	$60K	Hold	800	–	–	0.03%	301
2023 Q1	$61K	Hold	800	–	–	0.03%	295
2022 Q4	$63K	Hold	800	–	–	0.03%	274
2022 Q3	$57K	Hold	800	–	–	0.03%	264
2022 Q2	$60K	Hold	800	–	–	0.03%	268
2022 Q1	$64K	Hold	800	–	–	0.03%	266
2021 Q4	$65K	Hold	800	–	–	0.03%	255
2021 Q3	$62K	Hold	800	–	–	0.03%	255
2021 Q2	$64K	Hold	800	–	–	0.03%	263
2021 Q1	$63K	Hold	800	–	–	0.03%	259
2020 Q4	$57K	Hold	800	–	–	0.03%	259
2020 Q3	$51K	Hold	800	–	–	0.03%	279
2020 Q2	$52K	Buy	+800	New	+$49.7K	0.03%	270

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

FGA

Fortis Group Advisors Westwood, New Jersey $605M AUM 28.64% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Highlander Capital Management's PJP Position: Q1 2024 in Review

Highlander Capital Management held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2024 at 800 shares worth $64.1K. The position accounts for 0.02% of the portfolio, ranked #353.

Highlander Capital Management first reported a position in PJP in Q2 2020 and has held it in 16 quarters since. The position peaked at $65K in Q4 2021. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2024.

Highlander Capital Management held 800 shares of Invesco Pharmaceuticals ETF worth $64.1K as of Q1 2024.
Highlander Capital Management left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2024.
Invesco Pharmaceuticals ETF made up 0.02% of Highlander Capital Management's portfolio in Q1 2024, its #353 holding.
Highlander Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2020 and has held it in 16 quarters since.
Highlander Capital Management's Invesco Pharmaceuticals ETF position peaked at $65K in Q4 2021.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.